Publications by authors named "S Furmanek"

During the COVID-19 pandemic, a significant decline in was observed; however, re-emerged globally in 2023. Here, we describe a current outbreak of infections in the United States (US). More than 287 million patient records from all 50 states in the US were reviewed to identify patients with a diagnosis between 1 January 2017 and 30 September 2024.

View Article and Find Full Text PDF
Article Synopsis
  • * The study was retrospective and involved matching patients based on age and antibiotic usage to analyze recurrence rates, finding a significantly lower recurrence rate in the tapered vancomycin group (5.3%) compared to the standard group (28%).
  • * The results suggest that tapering vancomycin might be a more effective treatment for initial CDI infections, but more extensive studies are needed to confirm these findings.
View Article and Find Full Text PDF

Introduction: This study aims to explore the predictive roles of echocardiographic parameters and biomarkers in determining outcomes among hospitalized COVID-19 patients experiencing cardiovascular events.

Methods: A retrospective cohort study was conducted involving 49 COVID-19 patients who encountered cardiovascular events during hospitalization and underwent echocardiography. Our findings revealed notable associations between echocardiographic parameters and survival time.

View Article and Find Full Text PDF
Article Synopsis
  • Pneumonia is a common issue for people who have received solid organ transplants, affecting both their health and the success of the transplant.
  • A study analyzed clinical data from nearly 7,500 patients, separating solid organ transplant (SOT) recipients from non-transplant (NT) patients, revealing that SOT recipients tend to be younger, more often male, and have more health complications.
  • Findings indicate that SOT recipients face significantly higher mortality rates, especially at the one-year mark, highlighting the need for careful monitoring and follow-up care for these patients.
View Article and Find Full Text PDF

Background: The effects of SARS-CoV-2 have varied between significant waves of hospitalization.

Research Question: Are cardiovascular complications different among the first, delta and omicron waves of hospitalized COVID-19 pneumonia patients?

Study Design And Methods: This was a multi-centre retrospective study of patients hospitalized with SARS-CoV-2 pneumonia: 632 were hospitalized during the (March-July 2020), 1013 during the (September 2020-March 2021), and 323 during the (January 2022-July 2022). Patients were stratified by wave and occurrence of cardiovascular events.

View Article and Find Full Text PDF